Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
The Impact of Tele-coaching on the Physical Activity Level

The study aims to test the benefits of a semi-automated tele-coaching program to coach adult participants with chronic lung disease towards a more active lifestyle.

  • 0 views
  • 15 Dec, 2021
  • 1 location
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial (PFOX)

The fibrotic interstitial lung diseases (fILD) are characterised by lung scarring, distressing breathlessness and poor health-related quality of life. Exertional desaturation (low blood oxygen during exercise) is a hallmark of fILD, occurring in over 50% of patients. It is sometimes treated with ambulatory oxygen therapy (AOT), which involves breathing supplemental …

  • 3 views
  • 12 Feb, 2022
  • 1 location
Hyperpolarized Xenon-129 MR Imaging of the Lung

Over the past 10 years, electronic cigarettes (e-cigarettes, EC) have been commercialized as a "less harmful" alternative to traditional cigarettes.1,2 However, e-cigarettes are believed to cause pulmonary epithelial, endothelial and vascular dysfunction, and to cause murine phenotypes similar to those of human COPD. Recently, "spiked" vape juice has been linked …

  • 27 views
  • 26 Jan, 2021
  • 1 location
Sputum Microbiota and the Association With Clinical Parameters in Steady-state Acute Exacerbation and Convalescence of Bronchiectasis

Study 1 is a cross-sectional investigation. Patients with clinically stable bronchiectasis (symptoms, including cough frequency, sputum volume and purulence, within normal daily variations) will undergo baseline assessment consisting of history taking, routine sputum culture, 16srRNA pyrosequencing, measurement of sputum inflammatory markers, oxidative stress biomarkers and MMPs, and spirometry. Microbiota taxa …

spirometry
antibiotics
sputum culture
antibiotic therapy
cough
  • 29 views
  • 23 Jan, 2021
  • 1 location
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.

pamrevlumab
carbon monoxide
diffusion capacity of the lung for carbon monoxide
pirfenidone
nintedanib
  • 67 views
  • 18 Oct, 2022
  • 127 locations
  • 23 views
  • 24 Oct, 2022
  • 228 locations
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or

pirfenidone
diffusion capacity of the lung for carbon monoxide
carbon monoxide
forced vital capacity
nintedanib
  • 0 views
  • 28 Oct, 2022
  • 5 locations
A Phase III Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis (STARSCAPE)

with idiopathic pulmonary fibrosis (IPF).

lung biopsy
pirfenidone
diffusion capacity of the lung for carbon monoxide
carbon monoxide
6-minute walk test
  • 29 views
  • 24 Oct, 2022
  • 330 locations
  • 6 views
  • 23 Oct, 2022
  • 35 locations
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study

  • 0 views
  • 21 Oct, 2022
  • 1 location